Data suggest that when pharmacological Zn levels used, average daily gain and average daily feed intake can be improved with ...

The NEO-CYT study, sponsored by Fondazione Melanoma Onlus, will be evaluating MDNA11 in front-line therapy for resectable ...

Hopper Throttle MaxStax Soybean advanced planter box treatment copack on naked soybeans topped liquid seed treatment in the ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size, ...

Kidney research reveals a complex picture of life-saving treatments that show genuine promise but deliver frustratingly mixed ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...

ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, ...

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected ...

ASHEVILLE – The city is poised to begin the formal design process to create a “cultural corridor” between bustling Pack Square and The Block, the historic center of Asheville's Black business district ...

Researchers engineered “gyromorphs,” a new type of metamaterial that combines liquid-like randomness with large-scale structural patterns to block light from every direction. This innovation solves ...